FDA Clears the Provant Therapy System for Use by Patients with Metallic Implants

Posted on Sat/21/DecemberSat/21/December by AZBio

Clinicians can now treat the post-operative pain from joint replacements and spinal fusionsContinue reading→

Regenesis expects sale or final private round next year, CEO says

Posted on Wed/16/OctoberWed/16/October by AZBio

Regenesis Biomedical profiled in BioPharm Insight…
Continue reading→

Regenesis CEO Virginia Rybski Chats with Beaker.com

Posted on Mon/3/SeptemberWed/23/January by AZBio

Regenesis Biomedical’s CEO, Virginia Rybski, chats with the team at Beaker.com on her expereince at AdvaMed 2011 as well as shares a story of growth and progress.Continue reading→

Regenesis Biomedical Appoints Clinical Research Director

Posted on Tue/24/JanuaryTue/24/January by AZBio

Regenesis continues to invest in expanding the team and building the body of clinical evidence for the Provant Therapy SystemContinue reading→